Related Experiment Video
Updated: Feb 7, 2026
07:59
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
9.4K
Nanomedicines for Pediatric Cancers
Carlos Rodríguez-Nogales1,2, Yolanda González-Fernández1, Azucena Aldaz3
1Pharmacy and Pharmaceutical Technology Department , University of Navarra , Pamplona 31008 , Spain.
ACS Nano
|August 3, 2018
Summary
Nanotechnology offers a promising approach to reduce chemotherapy toxicity in children with cancer. This review explores nanomedicine
Area of Science:
- Pediatric Oncology
- Nanomedicine
- Drug Delivery Systems
Background:
- Current chemotherapy for pediatric cancers faces challenges with high toxicity and adult-derived dosing.
- Nanotechnology shows potential in reducing anticancer drug toxicity and improving therapeutic index.
Purpose of the Study:
- To review the current advancements of nanomedicine in pediatric cancer treatment.
- To discuss the clinical challenges and opportunities for nanomedicines in pediatric oncology.
Main Methods:
- Literature review of nanomedicine applications in pediatric cancer.
- Analysis of existing nanomedicine strategies and their potential clinical translation.
- Discussion of challenges in pediatric nanomedicine development and implementation.
Main Results:
- Nanotechnology can enhance the efficacy and safety of chemotherapeutic agents for pediatric cancers.
- Several nanomedicine approaches are being investigated for childhood cancer treatment.
- Significant hurdles remain in translating nanomedicines from research to clinical practice for children.
Conclusions:
- Nanomedicine holds considerable promise for improving pediatric cancer therapy by mitigating toxicity.
- Further research and development are crucial to overcome clinical challenges and realize the full potential of nanomedicines in pediatric oncology.
- Tailored nanomedicines for pediatric cancer are needed to address specific clinical requirements.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
266
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
314
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
314
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
237
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
237
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
305
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305
02:18Cancer
54.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.4K
02:12What is Cancer?
14.5K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.5K